Prostate Disease in the Aging Male
Publisher
Springer Netherlands
Reference184 articles.
1. Albanes, D., et al. (1996) Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst, 88(21): 1560–70.
2. Albertsen, P.C., et al. (1998) Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. Jama, 280(11): 975–80.
3. Albertsen, P.C., Hanley, J.A. and Fine, J. (2005) 20-year outcomes following conservative management of clinically localized prostate cancer. Jama, 293(17): 2095–101.
4. Allen, E.A., Kahane, H. and Epstein, J.I. (1998) Repeat biopsy strategies for men with atypical diagnoses on initial prostate needle biopsy. Urology, 52(5): 803–7.
5. Allen, D.J., et al. (2004) Does body-coil magnetic-resonance imaging have a role in the preoperative staging of patients with clinically localized prostate cancer? BJU Int, 94(4): 534–8.